{{org_field_logo}}

{{org_field_name}}

Registration Number: {{org_field_registration_no}}


PRN Medication Management Policy

1. Purpose

The purpose of this policy is to ensure that {{org_field_name}} manages PRN (Pro Re Nata) medications efficiently and safely, ensuring that they are administered correctly in accordance with prescriber instructions, service user needs, and regulatory requirements. PRN medication refers to medicines that are given as needed, rather than at scheduled times.

This policy ensures compliance with:

2. Scope

This policy applies to:

It covers:

This PRN policy is PRN-specific and must be implemented alongside the organisation’s overarching Medication Management and Administration Policy (DCW21), which sets out the full end-to-end medicines system (ordering/re-ordering, receipt, storage standards, reconciliation, audit processes, incident reporting and governance).

3. Definition and Purpose of PRN Medication

PRN medication is prescribed for:

PRN medications must only be administered when necessary and must follow strict assessment and documentation procedures.

4. PRN Medication Assessment and Care Planning

Before PRN medication is administered, a detailed assessment must be completed to determine:

Each service user receiving PRN medication must have a PRN Protocol included in their care plan, specifying:

4.1 Consent and mental capacity

Before PRN medicines support/administration, staff must confirm and record the person’s consent. Where there is reason to doubt capacity to consent to the PRN medicine at the time it is needed, staff must act in accordance with the Mental Capacity Act 2005: presume capacity unless established otherwise, take all practicable steps to support decision-making, and where the person lacks capacity, make and record a best-interests decision in line with the person’s known wishes, feelings, values and the views of those involved in their care.

4.2 Covert administration

Covert administration (disguising medicine in food or drink) must not be used unless it is formally agreed and documented following a best-interests process, with advice from the prescriber/pharmacist, and a clear written plan in the person’s care documentation. Covert administration must be reviewed regularly and stopped as soon as it is no longer necessary.

Where covert medication is provided, it must be administered in line with current best practice guidance.

5. Administration of PRN Medication

5.1 Decision-Making Before Administration

Before administering PRN medication, staff must:

5.2 Administering PRN Medication

5.3 Recording PRN Administration

After administering PRN medication, staff must document the following in the MAR chart:

6. Roles and Responsibilities

6.1 Responsibilities of the Registered Manager

6.2 Responsibilities of Care Workers

6.3 Responsibilities of Healthcare Professionals (GPs, Pharmacists)

6.4 Delegated medication-related tasks

Where a registered healthcare professional delegates a medication-related task (e.g., administration support that goes beyond routine medicines support), the service will follow the All Wales Guidelines for Delegation and ensure:

Delegated tasks must not be undertaken without clear written delegation and confirmation of competence.

7. Storage, controlled drugs, reconciliation and disposal

7.1 Storage in the person’s home (domiciliary setting)

PRN medicines must be stored in the person’s home in line with a risk assessment and the person’s care plan, balancing safety with the person’s independence. Medicines must be kept:

7.2 Controlled drugs (including PRN controlled medicines)

Where PRN medicines include controlled drugs, additional safeguards apply, including safe custody requirements (locked receptacle/safe as appropriate) and an audit trail of stock movement and administration. Controlled drugs must be managed in line with controlled drugs legislation.

7.3 Reconciliation and stock checks

The service must maintain an effective audit trail for PRN medicines it handles, including:

7.4 Disposal

Expired, discontinued or unwanted PRN medicines must be returned to a community pharmacy for safe disposal. Sharps (where applicable) must be disposed of using an appropriate sharps container in line with infection control arrangements.

8. Staff Training and Competency

9. Monitoring and Compliance

9.1 Reviewing PRN Medication Use

9.2 CIW Inspections and Compliance

9.3 Medicines audit

The Registered Manager (or delegated competent person) must ensure regular auditing of PRN medicines management, including storage arrangements, MAR/record quality, PRN protocol availability, evidence of review, controlled drug safeguards (where relevant), and learning from errors/near misses. Audits must be recorded, actions allocated, and outcomes reviewed to completion.

9.4 Incident reporting and CIW notifications

All medication errors, near misses, omissions, discrepancies, suspected adverse reactions, or safeguarding concerns must be reported immediately in line with the organisation’s incident procedure, recorded in the MAR/daily notes, investigated, and used for learning.

Where an incident meets CIW notification criteria (Schedule 3), the service must notify CIW without delay (usually within 24 hours) via CIW Online.

10. Related Policies

This policy should be read in conjunction with:

11. Policy Review

This policy will be reviewed annually or sooner if required by legislative changes, CIW regulations, or operational needs.


Responsible Person: {{org_field_registered_manager_first_name}} {{org_field_registered_manager_last_name}}
Reviewed on:
{{last_update_date}}
Next Review Date:
{{next_review_date}}
Copyright © {{current_year}} – {{org_field_name}}. All rights reserved.

Leave a Reply

Your email address will not be published. Required fields are marked *